Evidence that the β-acids fraction of hops reduces central GABAergic neurotransmission

Journal of Ethnopharmacology

Volumn 109, Issue 1, 2007, Pages 87-92

  Zanoli, P ^a   Zavatti, M ^a   Rivasi, M ^a   Brusiani, F ^a   Losi, G ^a   Puia, G ^a   Avallone, R ^a   Baraldi, M ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Acids; Elevated plus maze; Forced swimming test; GABAA receptor; Humulus lupulus; Locomotor behavior; Pentobarbital sleeping time

Indexed keywords

4 AMINOBUTYRIC ACID; BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; DIAZEPAM; FLUMAZENIL; HUMULUS LUPULUS EXTRACT; IMIPRAMINE; PENTOBARBITAL; PICROTOXIN; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN FUNCTION; CELL CULTURE; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONTROLLED STUDY; DEPRESSION; DISEASE EXACERBATION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; ELECTRIC CURRENT; ELECTROPHYSIOLOGY; EXPLORATORY BEHAVIOR; FORCED SWIMMING TEST; GABAERGIC TRANSMISSION; GRANULE CELL; HUMULUS LUPULUS; HYPNOSIS; IMMOBILIZATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MAZE TEST; NEUROTRANSMISSION; NONHUMAN; OBSERVATION; OPEN FIELD BEHAVIOR; RAT; SEIZURE; TASK PERFORMANCE;

ANIMALS; ANTIDEPRESSIVE AGENTS; BINDING, COMPETITIVE; CARBON DIOXIDE; CENTRAL NERVOUS SYSTEM; CEREBELLUM; DEPRESSION, CHEMICAL; ELECTROPHYSIOLOGY; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; HUMULUS; MALE; MAZE LEARNING; MOTOR ACTIVITY; PENTOBARBITAL; PICROTOXIN; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; SEIZURES; SLEEP; SOLVENTS; SWIMMING; SYNAPTIC TRANSMISSION;

HUMULUS LUPULUS;

EID: 33751418427     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2006.07.008     Document Type: Article

References (20)

1. Avallone R., Zanoli P., Puia G., Kleinschnitz M., Schreier P., and Baraldi M. Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla. Biochemical Pharmacology 59 (2000) 1387-1394
2. Chen W.-J., and Lin J.-K. Mechanisms of cancer chemoprevention by hop bitter acids (beer aroma) through induction of apoptosis mediated by Fas and caspase cascades. Journal of Agricultural and Food Chemistry 52 (2004) 55-64
3. Gallo V., Ciotti M.T., Coletti A., Aloisi F., and Levi G. Selective release of glutamate from cerebellar granule cells differentiating in culture. Proceedings of the National Academy of Sciences of the United States of America 79 (1982) 7919-7923
4. Hamill O.P., Marty A., Neher E., Sackmann B., and Sigworth F.J. Improved patch-clamp techniques for high-resolution current recording from cell and cell-free membrane patches. Pflugers Archiv: European Journal of Physiology 391 (1981) 85-100
5. Hänsel R., Wohlfart R., and Schmidt H. The sedativ-hypnotic principle of hops. 3. Communication: contents of 2-methyl-3-buten-2-ol in hops and hop preparations. Planta Medica 45 (1982) 224-228
6. Mizobuchi S., and Sato Y. Antifungal activities of hop bitter resins and related compounds. Agricultural and Biological Chemistry 49 (1985) 399-403
7. Murase K., Ryu P.D., and Randic M. Excitatory and inhibitory amino acids and peptide-induced responses in acutely isolated rat spinal dorsal horn neurons. Neuroscience Letters 103 (1989) 56-63
8. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods 14 (1985) 149-167
9. Porsolt R.D., Anton G., Blavt N., and Jalfre M. Behavioural despair in rats: a new animal model sensitive to antidepressant treatments. European Journal of Pharmacology 47 (1978) 379-391
10. Prut L., and Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviour: a review. European Journal of Pharmacology 463 (2003) 3-33
11. Shandra A.A., Mazarati A.M., Godlevsky L.S., and Vastyanov R.S. Chemical kindling: implications for antiepileptic drug-sensitive and resistant epilepsy models. Epilepsia 37 (1996) 269-274
12. Shimamura M., Hazato T., Ashino H., Yamamoto Y., Iwasaki E., Tobe H., Yamamoto K., and Yamamoto S. Inhibition of angiogenesis by humulone, a bitter acid from beer hop. Biochemical and Biophysical Research Communications 289 (2001) 220-224
13. Simpson W.J., and Smith A.R. Factors affecting antibacterial activity of hop compounds and their derivatives. Journal of Applied Bacteriology 72 (1992) 327-334
14. Tagashira M., Watanabe M., and Uemitsu N. Antioxidative activity of hop bitter acids and their analogues. Bioscience Biotechnology Biochemistry 59 (1995) 740-742
15. Verzele M., and Potter M.D.E. High-performance liquid chromatography of hop bitter substances. Journal of Chromatography 166 (1978) 320-326
16. Wohlfart R., Hänsel R., and Schmidt H. The sedativ-hypnotic principle of hops. 4. Communication: pharmacology of 2-methyl-3-buten-2-ol. Planta Medica 48 (1983) 120-123
17. Wohlfart R., Wurm G., Hänsel R., and Schmidt H. Detection of sedative hypnotic constituents. Part 5: degradation of humulones and lupulones to 2-methyl-3-butene-2-ol, a hop constituent possessing sedative hypnotic activity. Archiv der Pharmazie 316 (1983) 132-137
18. Yamamoto K., Wang J., Yamamoto S., and Tobe H. Suppression of cyclooxygenase-2 gene transcription by humulon of beer hop extract studied with reference to glucocorticoid. FEBS Letters 465 (2000) 103-106
19. Yusukawa K., Takeuchi M., and Takido M. Humulone, a bitter in the hop, inhibits tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Oncology 52 (1995) 156-158
20. Zanoli P., Rivasi M., Zavatti M., Brusiani F., and Baraldi M. New insight in the neuropharmacological activity of Humulus lupulus L. Journal of Ethnopharmacology 102 (2005) 102-106